Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Illinois?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. An Illinois resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Illinois-licensed provider, including by telehealth under the Illinois Telehealth Act (225 ILCS 150), which requires any professional treating a patient located in Illinois to be licensed or authorized in Illinois and to meet the in-person standard of care. Compounded peptides are available when eligible under federal 503A rules and dispensed by an Illinois pharmacy or a nonresident pharmacy licensed by the Illinois Department of Financial and Professional Regulation under the Pharmacy Practice Act (225 ILCS 85/16a).

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a Illinois resident get peptides by telehealth?

The Telehealth Act (225 ILCS 150) lets a health care professional practice telehealth services to the extent of the scope of practice in the professional's licensing act, consistent with the in-person standard of care (section 15), and requires a professional treating a patient located in Illinois to be licensed or authorized to practice in Illinois (section 10). Section 49.5 of the Medical Practice Act (225 ILCS 60/49.5) separately requires a physician engaged in telemedicine with Illinois patients to hold an Illinois license or permit. Section 5 of the Telehealth Act defines telehealth services as the evaluation, diagnosis, or interpretation of electronically transmitted patient-specific data that generates interaction or treatment recommendations, and says they include care delivered by an interactive telecommunications system, an asynchronous store and forward system (transmission that does not require real-time interaction), remote patient monitoring, e-visits, or virtual check-ins. E-visits and virtual check-ins are defined as communications with an established patient; the store and forward definition has no such limit. The Act also says it does not authorize care in a setting or manner not otherwise authorized by Illinois law. No Illinois statute sets a real-time video requirement for non-controlled prescriptions, and none addresses questionnaire-only prescribing. This record leaves asynchronous prescribing unknown because the law is silent on the point: asynchronous store and forward care is a recognized telehealth modality, but neither the Telehealth Act nor the Medical Practice Act says how a practitioner-patient relationship is formed or whether a first prescription may follow an asynchronous evaluation, and we found no Illinois Department of Financial and Professional Regulation guidance on it. [2] [5]

How does the Illinois pharmacy board treat compounding?

Compounding regulator for Illinois
BoardIllinois State Board of Pharmacy (Illinois Department of Financial and Professional Regulation)
Eligible substancesFollows the federal 503A framework

In Illinois, pharmacy licensing and discipline are handled by the Department of Financial and Professional Regulation (IDFPR) with the State Board of Pharmacy acting in an advisory role, under the Pharmacy Practice Act (225 ILCS 85) and the rules at 68 Illinois Administrative Code Part 1330. Illinois has no separate state bulks list, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Under 225 ILCS 85/16a, a nonresident pharmacy (one outside Illinois that ships, delivers, dispenses, or distributes prescription drugs into Illinois by any means, including over the internet) must be licensed by IDFPR and follow the Department's nonresident rules. Section 1330.640 (Pharmaceutical Compounding Standards) governs both sterile and nonsterile compounding by the official USP-NF (USP 47-NF 42, 2024 edition), limits dispensing of compounded drugs to valid patient-specific prescriptions except for defined nonsterile office use, and prohibits sterile compounding for office use unless the pharmacy is registered as a 503B outsourcing facility and licensed as a wholesale distributor; the former separate sterile section, 1330.670, is repealed. Section 1330.30(j) lists as unprofessional conduct dispensing or offering to dispense any drug that is not FDA approved, not in the USP-NF, and not on the FDA list of bulk drug substances that may be used in compounding. [1] [3] [4] [8]

Can you get compounded GLP-1s in Illinois?

Regulatory: Compounded GLP-1 limited

Illinois patients using telehealth GLP-1 programs should confirm the prescriber holds an Illinois license or permit and that the dispensing pharmacy holds an IDFPR nonresident pharmacy license. IDFPR has not issued its own GLP-1 rule, but it relays federal positions to licensees: its Pharmacy page posts FDA's July 2024 letter on adverse events with compounded semaglutide and tirzepatide, and its Spring 2025 compliance newsletter restated FDA's timelines that ended 503A enforcement discretion for compounded tirzepatide and set April 22, 2025 for semaglutide. [1] [2] [3] [5] [7] [11]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Illinois?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Illinois

What you'll actually find in Illinois, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [15] [16] [17]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [18]

What Illinois has done

PeptideAgent has not found a board or legislative action on peptides in Illinois.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [20] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [21] [22] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Illinois. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. [2] [5] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Illinois State Board of Pharmacy (Illinois Department of Financial and Professional Regulation); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [19]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [18]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [9] [23] [24]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [19] [25] [26]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [17] [26] [27]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [18] [28] [29] [30] [31] [32]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [18]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [19]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [17]
  • Pharmacy: Is this made for me on a prescription written in my name? [27]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [17] [26]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [17]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Illinois?

Only IDFPR-licensed pharmacies, including licensed nonresident pharmacies, may dispense prescription drugs to Illinois patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. The Illinois Food, Drug and Cosmetic Act, 410 ILCS 620/17, separately bars any person from selling, delivering, holding for sale, or giving away a new drug unless an application for it has been approved under section 505 of the federal act, and 68 Ill. Adm. Code 1330.30(j) makes dispensing a drug that is not FDA approved, not in the USP-NF, and not on the FDA bulks list unprofessional conduct for a licensee. [3] [4] [6] [12]

Peptide-specific notes for Illinois

Peptide-specific notes for Illinois
PeptideNote
SemaglutideAvailable branded by prescription from an Illinois-licensed provider, including by telehealth under 225 ILCS 150. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [5] [11]

Frequently asked questions

Can I get a GLP-1 prescription through telehealth in Illinois?

Yes, from a provider licensed or authorized to practice in Illinois. The Illinois Telehealth Act lets licensed professionals practice by telehealth within their scope of practice, held to the same standard of care as in-person visits. Illinois law does not settle whether a first prescription may follow an asynchronous evaluation with no live visit. It counts asynchronous store and forward care as telehealth, but it does not say how the practitioner-patient relationship is formed. [5]

Can a doctor licensed only in another state prescribe to me in Illinois?

Generally no. The Telehealth Act requires a professional treating a patient located in Illinois to be licensed or authorized in Illinois, and section 49.5 of the Medical Practice Act requires physicians practicing telemedicine with Illinois patients to hold an Illinois license or permit. [2] [5]

What does an out-of-state pharmacy need to ship compounded peptides to Illinois?

A nonresident pharmacy license from the Illinois Department of Financial and Professional Regulation under 225 ILCS 85/16a, which covers pharmacies that ship or deliver prescription drugs into Illinois by any means, including online. Check the IDFPR license lookup before ordering. [1] [3]

Can an Illinois pharmacy compound BPC-157?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: Illinois has no separate state bulks list, and 68 Ill. Adm. Code 1330.30(j) makes dispensing a drug that is not FDA approved, not in the USP-NF, and not on the FDA bulks list unprofessional conduct for a licensee. [4] [9] [10] [13] [14]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Illinois Department of Financial and Professional Regulation: Pharmacy (State Board of Pharmacy)
  2. [2]Illinois Medical Practice Act, 225 ILCS 60/49.5, Telemedicine
  3. [3]Illinois Pharmacy Practice Act, 225 ILCS 85/16a, Nonresident pharmacies
  4. [4]68 Illinois Administrative Code Part 1330, Pharmacy Practice Act rules (including sections 1330.30 and 1330.640)
  5. [5]Illinois Telehealth Act, 225 ILCS 150, sections 5, 10, and 15 (Illinois General Assembly)
  6. [6]Illinois Food, Drug and Cosmetic Act, 410 ILCS 620/17, New drugs (Illinois General Assembly)
  7. [7]IDFPR Compliance Capsule, Spring 2025 (semaglutide and tirzepatide compounding updates)
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  10. [10]FDA: Pharmacy Compounding Advisory CommitteeFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Illinois?. https://peptideagent.ai/legal/illinois
HTML link
<a href="https://peptideagent.ai/legal/illinois">Are peptides legal in Illinois?</a>, PeptideAgent, updated October 28, 2026.